Correlation Between DMK Pharmaceuticals and Cell Source

Can any of the company-specific risk be diversified away by investing in both DMK Pharmaceuticals and Cell Source at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DMK Pharmaceuticals and Cell Source into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between DMK Pharmaceuticals and Cell Source, you can compare the effects of market volatilities on DMK Pharmaceuticals and Cell Source and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DMK Pharmaceuticals with a short position of Cell Source. Check out your portfolio center. Please also check ongoing floating volatility patterns of DMK Pharmaceuticals and Cell Source.

Diversification Opportunities for DMK Pharmaceuticals and Cell Source

0.0

Correlation Coefficient

DMK Pharmaceuticals  Cell Source

Pay attention - limited upside

The 3 months correlation between DMK and Cell is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding DMK Pharmaceuticals and Cell Source in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cell Source and DMK Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DMK Pharmaceuticals are associated (or correlated) with Cell Source. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cell Source has no effect on the direction of DMK Pharmaceuticals i.e., DMK Pharmaceuticals and Cell Source go up and down completely randomly.

Pair Corralation between DMK Pharmaceuticals and Cell Source

If you would invest  32.00  in Cell Source on April 28, 2025 and sell it today you would earn a total of  8.00  from holding Cell Source or generate 25.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

DMK Pharmaceuticals  vs.  Cell Source

DMK Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days DMK Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, DMK Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Cell Source

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cell Source are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental indicators, Cell Source unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with DMK Pharmaceuticals and Cell Source

The main advantage of trading using opposite DMK Pharmaceuticals and Cell Source positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DMK Pharmaceuticals position performs unexpectedly, Cell Source can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cell Source will offset losses from the drop in Cell Source's long position.

The idea behind DMK Pharmaceuticals and Cell Source pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..